[1]许海波, 巩鹏.PPARs在梗阻性黄疸肝脏损伤中的作用[J].国际外科学杂志, 2007, 34 (7) :461-465.
|
[2]Mehmet C, MustafaK, Tarkan K, et al.Peroxisome prolifera-tors-activated alpha agonist treatment ameliorates hepaticdamage in rats with obstructive jaundice:an experimentalstudy[J].BMC Gastroenterology, 2007, 7 (44) :1-7.
|
[3]Lalloyer F, Staels B.Fibrates, glitazones, and peroxisomeproliferator-activated receptors[J].Arterioscler ThrombVasc Biol, 2010, 30 (5) :894-899.
|
[4]Post SM, Duez H, Gervois PP, et al.Fibrates suppress bileacid synthesis viaperoxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol27-hydroxylase expression[J].Arte-rioscler Thromb Vasc Biol, 2001, 21 (11) :1840-1845.
|
[5]Zollner G, Trauner M.Nuclear receptors as therapeutic tar-gets in cholestatic liver diseases[J].Br J Pharmacol, 2009, 156 (1) :7-27.
|
[6]Trauner M, Meier PJ, Boyer JL.Molecular pathogenesis ofcholestasis[J].New Eng J Med, 1998, 339 (17) :1217-1227.
|
[7]Aller MA, Arias JL, Prieto I, et al.Bile duct ligation:step-by-step to cholangiocyte inflammatory tumorigenesis[J].Eur J Gastroenterol Hepatol, 2010, 22 (6) :651-661.
|
[8]Kobayashi A, Suzuki Y, Kuno H, et al.Effects of fenofibrateon plasma and hepatic transaminase activities and hepatictransaminase gene expression in rats[J].J Toxico Sci, 2009, 34 (4) :377-387.
|
[9]张爱民, 徐德利, 徐峰, 等.梗阻性黄疸大鼠胆道引流时机对肝细胞凋亡的影响[J].肝胆外科杂志, 2008, 16 (5) :383-385.
|